Neuman John's Form 4 filing
SeaStar Medical Holding CorpICU · filed Feb 27, 2025
- Accession no.
- 0001213900-25-017946
- Filed
- Feb 27, 2025
- Trade date
- Jun 14-Dec 11, 2024
- Filing delay
- 258 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions. Open-market purchases total $153.2K. It was filed 258 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Neuman JohnCIK 0002026279 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 14, 2024 | Common Stock, par value $0.0001 per share | PPurchaseAcquired | +10,000 | $3.69F1 | +$36,900 | 10,000 | Direct | |
| Jun 17, 2024 | Common Stock, par value $0.0001 per share | PPurchaseAcquired | +10,000 | $4.35F2 | +$43,500 | 20,000 | Direct | |
| Aug 15, 2024 | Common Stock, par value $0.0001 per share | PPurchaseAcquired | +10,000 | $5.24F3 | +$52,400 | 30,000 | Direct | |
| Dec 11, 2024 | Common Stock, par value $0.0001 per share | PPurchaseAcquired | +10,000 | $2.04F4 | +$20,400 | 40,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
1. The price reported in Column 4 is a weighted average price of $3.6905. These shares were purchased in multiple transactions at prices ranging from $3.67 to $3.71, inclusive. The reporting person undertakes to provide, upon request by the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.
- F2
2. The price reported in Column 4 is a weighted average price of $4.3521. These shares were purchased in multiple transactions at prices ranging from $4.29 to $4.37, inclusive. The reporting person undertakes to provide, upon request by the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
3. The price reported in Column 4 is a weighted average price of $5.2396. These shares were purchased in multiple transactions at prices ranging from $5.19 to $5.24, inclusive. The reporting person undertakes to provide, upon request by the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
4. The price reported in Column 4 is a weighted average price of $2.0405. These shares were purchased in multiple transactions at prices ranging from $2.01 to $2.06, inclusive. The reporting person undertakes to provide, upon request by the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.
Remarks
These transactions are being reported late due to an inadvertent administrative error.